Role of Vitamin D Levels in COVID-19 Disease Severity: A Multicenter Retrospective Study from Qatar

Jazar et al., Pakistan Journal of Biological Sciences, doi:10.3923/pjbs.2025.640.648, Dec 2025
Mortality 21% improvement lower risk ← → higher risk ICU time 43% Hospitalization time 20% Vitamin D for COVID-19  Jazar et al.  SUFFICIENCY   Are vitamin D levels associated with COVID-19 outcomes? Retrospective 296 patients in Qatar Shorter ICU admission with higher vitamin D levels (p=0.04) c19early.org Jazar et al., Pakistan J. Biological S.., Dec 2025 0 0.5 1 1.5 2+ RR
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 136 studies, recognized in 18 countries.
No treatment is 100% effective. Protocols combine treatments.
6,300+ studies for 210+ treatments. c19early.org
Retrospective 296 hospitalized COVID-19 patients in Qatar showing longer ICU stays with vitamin D deficiency. No significant difference was found for hospital length of stay or mortality.
This is the 227th of 228 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001.
risk of death, 20.6% lower, RR 0.79, p = 0.78, high D levels (≥20 ng/mL) 4 of 93 (4.3%), low D levels (<20 ng/mL) 11 of 203 (5.4%), NNT 89.
ICU time, 42.6% lower, relative time 0.57, p = 0.04, high D levels (≥20 ng/mL) mean 11.3 (±11.0) n=93, low D levels (<20 ng/mL) mean 19.7 (±22.6) n=203.
hospitalization time, 20.0% lower, relative time 0.80, p = 0.23, high D levels (≥20 ng/mL) mean 14.8 (±8.8) n=93, low D levels (<20 ng/mL) mean 18.5 (±16.8) n=203.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Jazar et al., 25 Dec 2025, retrospective, Qatar, peer-reviewed, mean age 46.6, 7 authors.
$0 $500 $1,000+ Efficacy vs. cost for COVID-19 treatment protocols c19early.org January 2026 Qatar United Kingdom Russia USA Sudan Angola Colombia Kenya Mozambique Pakistan Argentina Peru Philippines Vietnam Spain Brazil Italy France Japan China Uzbekistan Nepal Ethiopia Iran Ghana Mexico South Korea Germany Bangladesh Saudi Arabia Algeria Morocco Yemen India DR Congo Madagascar Thailand Uganda Venezuela Nigeria Egypt Bolivia Taiwan Zambia Fiji Bosnia-Herzegovina Ukraine Côte d'Ivoire Bulgaria Greece Iceland New Zealand Mongolia Israel Hong Kong Belarus Panama Serbia CAR Qatar favored high-profit treatments.The average efficacy of treatments was moderate.High-cost protocols reduce early treatment, andforgo complementary/synergistic benefits. More effective More expensive 75% 50% 25% ≤0%
$0 $500 $1,000+ Efficacy vs. cost for COVID-19treatment protocols worldwide c19early.org January 2026 Qatar United Kingdom Russia USA Sudan Angola Colombia Kenya Mozambique Pakistan Argentina Peru Philippines Vietnam Spain Brazil Italy France Japan China Uzbekistan Nepal Ethiopia Iran Ghana Mexico South Korea Germany Bangladesh Saudi Arabia Algeria Morocco Yemen India DR Congo Madagascar Thailand Uganda Venezuela Nigeria Egypt Bolivia Taiwan Zambia Fiji Ukraine Côte d'Ivoire Eritrea Bulgaria Greece Slovakia Singapore New Zealand Mongolia Israel Hong Kong Belarus Panama Serbia Syria Qatar favored high-profit treatments.The average efficacy was moderate.High-cost protocols reduce early treatment,and forgo complementary/synergistic benefits. More effective More expensive 75% 50% 25% ≤0%
Role of Vitamin D Levels in COVID-19 Disease Severity: A Multicenter Retrospective Study from Qatar
Abdelelah S Jazar, Raed B Alalaween, Reem K Al-Saadi, Noora M Aljaffali, Zohair A Al Arabi, Mai A Ghabashi, Firas S Azzeh
Pakistan Journal of Biological Sciences, doi:10.3923/pjbs.2025.640.648
Background and Objective: Up to now, evidence remains inconclusive about how vitamin D (VD) status relates to the severity of COVID-19 among hospitalized patients. The present study aims to explore the impact of VD status on the severity of COVID-19 among hospitalized patients in Qatar and examine its effects on health factors related to the disease. Materials and Methods: A retrospective, cross-sectional, multicenter study was conducted at Hamad Medical Corporation in Qatar from March, 2020 to May, 2021. Demographics, laboratory values, comorbidities, clinical outcomes and some inflammatory markers were retrieved from the hospitalʼs system. The severity of COVID-19 disease was determined by an elevated neutrophil-lymphocyte ratio (NLR). A patient with VD levels less than 20 ng/mL was considered deficient. Data were analyzed using SPSS v22, with significance set at p<0.05, employing Mann-Whitney, Chi-squared and correlation tests as appropriate. Results: The VD deficiency was common (68.6%), with longer ICU stays observed in deficient patients compared to those with normal VD status (19.7 vs. 11.2; p = 0.04). There was a trend of higher NLR with lower VD levels. No significant difference in interleukin-6 levels was found between the deficient and sufficient VD groups (60.6±64.1 vs. 41.2±45.2 pg/mL; p = 0.472). Conclusion: This study highlights the link between VD status and COVID-19 disease severity. The findings suggest that suboptimal levels of VD in COVID-19 patients may be potentially associated with increased length of stay in the ICU and have a minor impact on the pro-inflammatory state.
References
Adami, Giollo, Fassio, Benini, Bertoldo, Vitamin D and disease severity in coronavirus disease 19 (COVID-19), Reumatismo
Alkhafaji, Al Argan, Albaker, Al Elq, Al-Hariri, The impact of vitamin D level on the severity and outcome of hospitalized patients with COVID-19 disease, Int. J. Gen. Med
Bassatne, Basbous, Chakhtoura, Zein, Rahme et al., The link between COVID-19 and vitamin D (VIVID): A systematic review and meta-analysis, Metabolism, doi:10.1016/j.metabol.2021.154753
Begum, Mirghani, The role of vitamin D in COVID-19 survival and prevention: A meta-analysis, Sudan J. Med. Sci
Benskin, A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency, Front. Public Health, doi:10.3389/fpubh.2020.00513
Carmeliet, Dermauw, Bouillon, Vitamin D signaling in calcium and bone homeostasis: A delicate balance, Best Pract. Res. Clin. Endocrinol. Metab
Chen, Li, Zheng, Zhou, Liu, Factors associated with duration of hospital stay and complications in patients with COVID-19, J. Public Health Emerg
Demir, Demir, Aygun, Vitamin D deficiency is associated with COVID 19 positivity and severity of the disease, J. Med. Virol
Dhar, Vishnupriyan, Damodar, Gujar, Das, IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: Results from meta-analysis and regression, Heliyon, doi:10.1016/j.heliyon.2021.e06155
Di Filippo, Uygur, Locatelli, Nannipieri, Frara et al., Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization, Endocrine
Ebrahimzadeh, Mohseni, Narimani, Ebrahimzadeh, Kazemi, Association between vitamin D status and risk of COVID-19 in-hospital mortality: A systematic review and meta-analysis of observational studies, Crit. Rev. Food Sci. Nutr
Han, Ma, Li, Liu, Zhao, Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors, Emerging Microbes Infect
Hekmatnia, Rahmani, Feili, Ebrahimzadeh, A review of the effect of COVID-19 on immune responses of the body, J. Fam. Med. Primary Care
Hernández, Nan, Fernandez-Ayala, García-Unzueta, Hernández-Hernández, Vitamin D status in hospitalized patients with SARS-CoV-2 infection, J. Clin. Endocrinol. Metab
Herold, Jurinovic, Arnreich, Lipworth, Hellmuth, Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19, J. Allergy Clin. Immunol
Hopefl, Ben-Eltriki, Deb, Association between vitamin D levels and inflammatory markers in COVID-19 patients: A meta-analysis of observational studies, J. Pharm. Pharm. Sci
Khojah, Ahmed, Al-Thagfan, Alahmadi, Abdou, The impact of serum levels of vitamin D3 and its metabolites on the prognosis and disease severity of COVID-19, Nutrients
Konikowska, Kiliñ-Pstrusi½ska, Matera-Witkiewicz, Kujawa, Adamik, Association of serum vitamin D concentration with the final course of hospitalization in patients with COVID-19, Front. Immunol, doi:10.3389/fimmu.2023.1231813
Luo, Liao, Shen, Li, Cheng, Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people, J. Nutr
Mallah, Ghorab, Al-Salmi, Abdellatif, Tharmaratnam, COVID-19: Breaking down a global health crisis, Ann. Clin. Microbiol. Antimicrob
Mcelvaney, Mcevoy, Mcelvaney, Carroll, Murphy, Characterization of the inflammatory response to severe COVID-19 illness, Am. J. Respir. Crit. Care Med
Nielsen, Junker, Boelt, Cohen, Munger, Vitamin D status and severity of COVID-19, Sci. Rep
Pereira, Damascena, Azevedo, De Almeida Oliveira, Da Mota et al., Vitamin D deficiency aggravates COVID-19: Systematic review and meta-analysis, Crit. Rev. Food Sci. Nutr
Pimentel, Vega, Pichard, Low vitamin D levels and increased neutrophil in patients admitted at ICU with COVID-19, Clin. Nutr. ESPEN
Qiu, Bao, Tian, Zhang, Pan, Vitamin D status in hospitalized COVID-19 patients is associated with disease severity and IL-5 production, Virol. J
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger et al., Vitamin D deficiency and outcome of COVID-19 patients, Nutrients, doi:10.3390/nu12092757
Rathod, Ahirwar, Banerjee, Joshi, Khot, Association of vitamin D with the severity of disease and mortality in COVID-19, Ann. Afr. Med
Ricci, Pagliuca, Dʼascanio, Innammorato, De Vitis, Circulating vitamin D levels status and clinical prognostic indices in COVID-19 patients, Respir. Res
Shah, Saxena, Mavalankar, Vitamin D supplementation, COVID-19 and disease severity: A metaanalysis, QJM: Int. J. Med
Simadibrata, Calvin, Wijaya, Ibrahim, Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis, Am. J. Emerg. Med
Singh, Nimavat, Singh, Ahmad, Sinha, Prevalence of low level of vitamin D among COVID-19 patients and associated risk factors in India-A hospital-based study, Int. J. Gen. Med
Sîrbe, Rednic, Grama, Pop, An update on the effects of vitamin D on the immune system and autoimmune diseases, Int. J. Mol. Sci, doi:10.3390/ijms23179784
Tekin, Yassa, Birol, Unlu, Sahin, Vitamin D status is not associated with clinical severity of COVID-19 in pregnant women, Eur. J. Nutr
Tentolouris, Achilla, Anastasiou, Eleftheriadou, Tentolouris, The association of vitamin D receptor polymorphisms with COVID-19 severity, Nutrients
Ye, Tang, Liao, Shaw, Deng, Does serum vitamin D level affect COVID-19 infection and its severity?-A case-control study, J. Am. Coll. Nutr
DOI record: { "DOI": "10.3923/pjbs.2025.640.648", "ISSN": [ "1028-8880" ], "URL": "http://dx.doi.org/10.3923/pjbs.2025.640.648", "author": [ { "affiliation": [], "family": "Jazar", "given": "Abdelelah S.", "sequence": "first" }, { "affiliation": [], "family": "Alalaween", "given": "Raed B.", "sequence": "additional" }, { "affiliation": [], "family": "Al-Saadi", "given": "Reem K.", "sequence": "additional" }, { "affiliation": [], "family": "Aljaffali", "given": "Noora M.", "sequence": "additional" }, { "affiliation": [], "family": "Al Arabi", "given": "Zohair A.", "sequence": "additional" }, { "affiliation": [], "family": "Ghabashi", "given": "Mai A.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-1400-5465", "affiliation": [], "authenticated-orcid": true, "family": "Azzeh", "given": "Firas S.", "sequence": "additional" } ], "container-title": "Pakistan Journal of Biological Sciences", "container-title-short": "Pakistan J. of Biological Sciences", "content-domain": { "crossmark-restriction": false, "domain": [ "scialert.net" ] }, "created": { "date-parts": [ [ 2025, 12, 24 ] ], "date-time": "2025-12-24T10:43:29Z", "timestamp": 1766573009000 }, "deposited": { "date-parts": [ [ 2025, 12, 24 ] ], "date-time": "2025-12-24T10:44:01Z", "timestamp": 1766573041000 }, "indexed": { "date-parts": [ [ 2025, 12, 24 ] ], "date-time": "2025-12-24T10:45:25Z", "timestamp": 1766573125373, "version": "3.48.0" }, "is-referenced-by-count": 0, "issue": "10", "issued": { "date-parts": [ [ 2025, 12, 25 ] ] }, "journal-issue": { "issue": "10", "published-print": { "date-parts": [ [ 2025, 12, 25 ] ] } }, "link": [ { "URL": "https://www.scialert.net/fulltext/?doi=pjbs.2025.640.648", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "2297", "original-title": [], "page": "640-648", "prefix": "10.3923", "published": { "date-parts": [ [ 2025, 12, 25 ] ] }, "published-print": { "date-parts": [ [ 2025, 12, 25 ] ] }, "publisher": "Science Alert", "reference": [ { "DOI": "10.4103/jfmpc.jfmpc_677_21", "doi-asserted-by": "publisher", "key": "ref1" }, { "DOI": "10.1093/qjmed/hcab009", "doi-asserted-by": "publisher", "key": "ref2" }, { "DOI": "10.1016/J.BEEM.2015.06.001", "doi-asserted-by": "publisher", "key": "ref3" }, { "DOI": "10.1093/JN/NXAA332", "doi-asserted-by": "publisher", "key": "ref4" }, { "DOI": "10.1080/10408398.2020.1841090", "doi-asserted-by": "publisher", "key": "ref5" }, { "DOI": "10.4081/REUMATISMO.2020.1333", "doi-asserted-by": "publisher", "key": "ref6" }, { "DOI": "10.1080/07315724.2020.1826005", "doi-asserted-by": "publisher", "key": "ref7" }, { "DOI": "10.2147/IJGM.S346169", "doi-asserted-by": "publisher", "key": "ref8" }, { "DOI": "10.1007/S00394-021-02709-7", "doi-asserted-by": "publisher", "key": "ref9" }, { "DOI": "10.1016/J.CLNESP.2021.05.021", "doi-asserted-by": "publisher", "key": "ref10" }, { "DOI": "10.1002/jmv.26832", "doi-asserted-by": "publisher", "key": "ref11" }, { "DOI": "10.1210/clinem/dgaa733", "doi-asserted-by": "publisher", "key": "ref12" }, { "DOI": "10.2147/IJGM.S309003", "doi-asserted-by": "publisher", "key": "ref13" }, { "DOI": "10.18433/jpps32518", "doi-asserted-by": "publisher", "key": "ref14" }, { "DOI": "10.4103/aam.aam_21_22", "doi-asserted-by": "publisher", "key": "ref15" }, { "DOI": "10.1007/s12020-023-03331-9", "doi-asserted-by": "publisher", "key": "ref16" }, { "DOI": "10.1080/10408398.2021.2012419", "doi-asserted-by": "publisher", "key": "ref17" }, { "DOI": "10.1016/j.ajem.2021.01.006", "doi-asserted-by": "publisher", "key": "ref18" }, { "DOI": "10.1080/22221751.2020.1770129", "doi-asserted-by": "publisher", "key": "ref19" }, { "DOI": "10.1164/rccm.202005-1583OC", "doi-asserted-by": "publisher", "key": "ref20" }, { "DOI": "10.1016/j.jaci.2020.05.008", "doi-asserted-by": "publisher", "key": "ref21" }, { "DOI": "10.18502/sjms.v19i1.15776", "doi-asserted-by": "publisher", "key": "ref22" } ], "reference-count": 22, "references-count": 22, "relation": {}, "resource": { "primary": { "URL": "https://www.scialert.net/abstract/?doi=pjbs.2025.640.648" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Role of Vitamin D Levels in COVID-19 Disease Severity: A Multicenter Retrospective Study from Qatar", "type": "journal-article", "update-policy": "https://doi.org/10.3923/crossmark-policy", "volume": "28" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit